Novel combination of salinomycin and resveratrol synergistically enhances the anti-proliferative and pro-apoptotic effects on human breast cancer cells

Apoptosis

Volumn 22, Issue 10, 2017, Pages 1246-1259

  Dewangan, Jayant ^a   Tandon, Divya ^a   Srivastava, Sonal ^a   Verma, Ajeet Kumar ^a   Yapuri, Ashok ^a,b   Rath, Srikanta Kumar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b National Institute of Pharmaceutical Education and Research (NIPER)   (India)

Author keywords

Apoptosis; Breast cancer; MAPK; Resveratrol; Salinomycin; Synergism

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; RESVERATROL; SALINOMYCIN; SUPEROXIDE DISMUTASE; ANTINEOPLASTIC AGENT; PYRAN DERIVATIVE; STILBENE DERIVATIVE;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; IC50; MCF-10A CELL LINE; MCF-7 CELL LINE; MDA-MB-231 CELL LINE; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T-47D CELL LINE; BREAST TUMOR; CELL PROLIFERATION; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; MAPK SIGNALING; METABOLISM; PATHOPHYSIOLOGY; TUMOR CELL LINE; TUMOR STEM CELL ASSAY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SYNERGISM; FEMALE; FLOW CYTOMETRY; HUMANS; INHIBITORY CONCENTRATION 50; MAP KINASE SIGNALING SYSTEM; MCF-7 CELLS; PYRANS; REACTIVE OXYGEN SPECIES; STILBENES; TUMOR STEM CELL ASSAY;

EID: 85026896335     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-017-1394-y     Document Type: Article

References (43)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108
2. Carter LG, D’Orazio JA, Pearson KJ. (2014) Resveratrol and cancer: focus on in vivo evidence. Endocr Related Cancer 21:R209–R225
3. Tinoco G, Warsch S, Gluck S, Avancha K, Montero AJ (2013) Treating breast cancer in the 21st century: emerging biological therapies. J Cancer 4:117–132
4. Higgins MJ, Baselga J (2011) Targeted therapies for breast cancer. J Clin Invest 121:3797–3803
5. Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385–427
6. Suntharalingam K, Lin W, Johnstone TC et al (2014) A breast cancer stem cell-selective, mammospheres-potent osmium(VI) nitrido complex. J Am Chem Soc 136:14413–14416
7. Chen LS, Wang AX, Dong B, Pu KF, Yuan LH, Zhu YM (2012) A new prospect in cancer therapy: targeting cancer stem cells to eradicate cancer. Chinese. J Cancer 31:564–572
8. Jangamreddy JR, Ghavami S, Grabarek J et al (2013) Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: differences between primary and cancer cells. Biochim Biophys Acta 1833:2057–2069
9. Fuchs D, Heinold A, Opelz G, Daniel V, Naujokat C (2009) Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells. Biochem Biophys Res Commun 390:743–749
10. Huczynski A, Janczak J, Antoszczak M, Wietrzyk J, Maj E, Brzezinski B (2012) Antiproliferative activity of salinomycin and its derivatives. Bioorg Med Chem Lett 22:7146–7150
11. Ketola K, Hilvo M, Hyotylainen T et al (2012) Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress. Br J Cancer 106:99–106
12. Wang F, He L, Dai WQ et al (2012) Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo. PLoS ONE 7:e50638
13. Zhou S, Wang F, Wong ET et al (2013) Salinomycin: a novel anti-cancer agent with known anti-coccidial activities. Curr Med Chem 20:4095–4101
14. Gupta PB, Onder TT, Jiang G et al (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138:645–659
15. Dewangan J, Srivastava S, Rath SK (2017) Salinomycin: a new paradigm in cancer therapy. Tumour Biol 39:1010428317695035
16. Ojo OO, Bhadauria S, Rath SK (2013) Dose-dependent adverse effects of salinomycin on male reproductive organs and fertility in mice. PLoS ONE 8:e69086
17. Aleman M, Magdesian KG, Peterson TS, Galey FD (2007) Salinomycin toxicosis in horses. J Am Vet Med Assoc 230:1822–1826
18. Sinha D, Sarkar N, Biswas J, Bishayee A. (2016) Resveratrol for breast cancer prevention and therapy: preclinical evidence and molecular mechanisms. Seminars in cancer biology. Academic Press, Cambridge
19. Fremont L (2000) Biological effects of resveratrol. Life Sci 66:663–673
20. Baur JA, Sinclair DA. (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493–506
21. Shi J, Zeng Q, Liu Y, Pan Z (2012) Alternaria sp. MG1, a resveratrol-producing fungus: isolation, identification, and optimal cultivation conditions for resveratrol production. Appl Microbiol Biotechnol 95:369–379
22. Subbaramaiah K, Chung WJ, Michaluart P et al (1998) Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 273:21875–21882
23. Le Corre L, Chalabi N, Delort L, Bignon YJ, Bernard-Gallon DJ. (2005) Resveratrol and breast cancer chemoprevention: molecular mechanisms. Molecular Nutr Food Res 49:462–471
24. Gupta SC, Kannappan R, Reuter S, Kim JH, Aggarwal BB (2011) Chemosensitization of tumors by resveratrol. Ann N Y Acad Sci 1215:150–160
25. Chou TC (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58:621–681
26. Holliday DL, Speirs V. (2011) Choosing the right cell line for breast cancer research. Breast Cancer Res 13:215
27. Chou TC, Talalay P (1981) Generalized equations for the analysis of inhibitions of Michaelis–Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. European journal of biochemistry/FEBS 115:207–216
28. Chou TC, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27–55
29. Chou TC (2010) Drug combination studies and their synergy quantification using the Chou–Talalay method. Cancer Res 70:440–446
30. Saraste A, Pulkki K (2000) Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 45:528–537
31. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184:39–51
32. Michaeloudes C, Sukkar MB, Khorasani NM, Bhavsar PK, Chung KF (2011) TGF-beta regulates Nox4, MnSOD and catalase expression, and IL-6 release in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 300:L295–L304
33. Baluchamy S, Ravichandran P, Ramesh V et al (2012) Reactive oxygen species mediated tissue damage in high energy proton irradiated mouse brain. Mol Cell Biochem 360:189–195
34. Kim SJ, Jung HJ, Lim CJ (2011) Disruption of redox homeostasis and induction of apoptosis by suppression of glutathione synthetase expression in a mammalian cell line. Free Radic Res 45:1040–1051
35. Schrader M, Fahimi HD (2006) Peroxisomes and oxidative stress. Biochim Biophys Acta 1763:1755–1766
36. Patrushev N, Seidel-Rogol B, Salazar G (2012) Angiotensin II requires zinc and downregulation of the zinc transporters ZnT3 and ZnT10 to induce senescence of vascular smooth muscle cells. PLoS ONE 7:e33211
37. Chau LY (2015) Heme oxygenase-1: emerging target of cancer therapy. J Biomed Sci 22:22
38. Verdoodt B, Vogt M, Schmitz I, Liffers ST, Tannapfel A, Mirmohammadsadegh A (2012) Salinomycin induces autophagy in colon and breast cancer cells with concomitant generation of reactive oxygen species. PLoS ONE 7:e44132
39. Kumar S (2007) Caspase function in programmed cell death. Cell Death Differ 14:32–43
40. McIlwain DR, Berger T, Mak TW. (2013) Caspase functions in cell death and disease. Cold Spring Harbor Perspect Biol 5:a008656
41. Huang WR, Zhang Y, Tang X (2014) Shikonin inhibits the proliferation of human lens epithelial cells by inducing apoptosis through ROS and caspase-dependent pathway. Molecules 19:7785–7797
42. Germain M, Affar EB, D’Amours D, Dixit VM, Salvesen GS, Poirier GG (1999) Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7. J Biol Chem 274:28379–28384
43. Son Y, Cheong YK, Kim NH, Chung HT, Kang DG, Pae HO (2011) Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways? J Signal Transduct 2011:792639